Kerwyn Foo

1.6k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

Kerwyn Foo is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kerwyn Foo has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiation, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kerwyn Foo's work include Advanced Radiotherapy Techniques (13 papers), Radiation Dose and Imaging (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Kerwyn Foo is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Radiation Dose and Imaging (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Kerwyn Foo collaborates with scholars based in Australia, United Kingdom and United States. Kerwyn Foo's co-authors include Bryan Burmeister, John Zalcberg, B. Mark Smithers, John Simes, Val Gebski, Nicholas Hardcastle, Peter Metcalfe, Andrew Miller, S. Gulliford and Martin Carolan and has published in prestigious journals such as The Lancet Oncology, International Journal of Radiation Oncology*Biology*Physics and Physics in Medicine and Biology.

In The Last Decade

Kerwyn Foo

17 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

2007 912 citations Val Gebski, Bryan Burmeister et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kerwyn Foo Australia	9	993	878	265	190	174	17	1.3k
Isabelle Martel‐Lafay France	13	547 0.6×	423 0.5×	91 0.3×	184 1.0×	268 1.5×	41	818
Tibetha Santucci United States	12	708 0.7×	397 0.5×	81 0.3×	155 0.8×	236 1.4×	18	1.1k
Robin S. Macherey United States	11	620 0.6×	325 0.4×	56 0.2×	150 0.8×	222 1.3×	14	967
Daphna Y. Spiegel United States	8	605 0.6×	375 0.4×	339 1.3×	77 0.4×	119 0.7×	24	997
Kiyomi Mera Japan	11	416 0.4×	378 0.4×	29 0.1×	68 0.4×	130 0.7×	21	620
Adrian Wong United States	11	258 0.3×	325 0.4×	194 0.7×	153 0.8×	294 1.7×	15	642
É. Lartigau France	11	156 0.2×	141 0.2×	153 0.6×	158 0.8×	72 0.4×	48	463
Dongfu Chen China	19	721 0.7×	328 0.4×	67 0.3×	199 1.0×	343 2.0×	71	970
Ruth Peter United States	8	444 0.4×	111 0.1×	338 1.3×	185 1.0×	105 0.6×	11	629
S. Racadot France	16	330 0.3×	375 0.4×	132 0.5×	95 0.5×	290 1.7×	72	863

Countries citing papers authored by Kerwyn Foo

Since Specialization

Citations

This map shows the geographic impact of Kerwyn Foo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerwyn Foo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerwyn Foo more than expected).

Fields of papers citing papers by Kerwyn Foo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerwyn Foo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerwyn Foo. The network helps show where Kerwyn Foo may publish in the future.

Co-authorship network of co-authors of Kerwyn Foo

This figure shows the co-authorship network connecting the top 25 collaborators of Kerwyn Foo. A scholar is included among the top collaborators of Kerwyn Foo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerwyn Foo. Kerwyn Foo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Khaw, Pearly, Viet Do, Karen Lim, et al.. (2021). Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial. Clinical Oncology. 34(3). 198–204. 2 indexed citations

Jones, Michael P., et al.. (2018). The impact of contour variation on tumour control probability in anal cancer. Radiation Oncology. 13(1). 97–97. 6 indexed citations

Jameson, Michael, Jo Ann McNamara, Michael Bailey, et al.. (2016). Results of the Australasian (Trans‐Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC‐3 trial. Journal of Medical Imaging and Radiation Oncology. 60(4). 554–559. 4 indexed citations

Ebert, Martin A., Kerwyn Foo, Annette Haworth, et al.. (2015). Gastrointestinal Dose-Histogram Effects in the Context of Dose-Volume–Constrained Prostate Radiation Therapy: Analysis of Data From the RADAR Prostate Radiation Therapy Trial. International Journal of Radiation Oncology*Biology*Physics. 91(3). 595–603. 30 indexed citations

Ebert, Martin A., S. Gulliford, Florian Buettner, et al.. (2014). Two non-parametric methods for derivation of constraints from radiotherapy dose–histogram data. Physics in Medicine and Biology. 59(13). N101–N111. 2 indexed citations

Yahya, Noorazrul, Martin A. Ebert, Max Bulsara, et al.. (2014). Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial. Radiation Oncology. 9(1). 282–282. 7 indexed citations

Ebert, Martin A., Kerwyn Foo, Annette Haworth, et al.. (2014). Derivation and representation of dose-volume response from large clinical trial data sets: an example from the RADAR prostate radiotherapy trial. Journal of Physics Conference Series. 489. 12090–12090. 1 indexed citations

Carolan, Martin, Bradley M. Oborn, Kerwyn Foo, et al.. (2014). An MLE method for finding LKB NTCP model parameters using Monte Carlo uncertainty estimates. Journal of Physics Conference Series. 489. 12087–12087. 2 indexed citations

Ch’ng, Sydney, Kan Gao, Kerwyn Foo, et al.. (2013). Prospective quality of life assessment between treatment groups for oral cavity squamous cell carcinoma. Head & Neck. 36(6). 834–840. 14 indexed citations

10.

Hruby, George, et al.. (2012). Constrained‐beam inverse planning for intensity‐modulated radiation therapy of prostate cancer patients with bilateral hip prostheses. Journal of Medical Imaging and Radiation Oncology. 56(6). 703–707. 7 indexed citations

11.

Kelly, Andrew, Nicholas Hardcastle, Peter Metcalfe, et al.. (2011). Surface dosimetry for breast radiotherapy in the presence of immobilization cast material. Physics in Medicine and Biology. 56(4). 1001–1013. 38 indexed citations

12.

Hardcastle, Nicholas, Wolfgang A. Tomé, Kerwyn Foo, et al.. (2010). Comparison of Prostate IMRT and VMAT Biologically Optimised Treatment Plans. Medical dosimetry. 36(3). 292–298. 59 indexed citations

13.

Hardcastle, Nicholas, A. Davies, Kerwyn Foo, Andrew Miller, & Peter Metcalfe. (2010). Rectal dose reduction with IMRT for prostate radiotherapy. Journal of Medical Imaging and Radiation Oncology. 54(3). 235–248. 18 indexed citations

14.

Gulliford, S., Kerwyn Foo, Rachel C. Morgan, et al.. (2009). Dose–Volume Constraints to Reduce Rectal Side Effects From Prostate Radiotherapy: Evidence From MRC RT01 Trial ISRCTN 47772397. International Journal of Radiation Oncology*Biology*Physics. 76(3). 747–754. 109 indexed citations

15.

Murthy, Vedang, Karen Thomas, Kerwyn Foo, et al.. (2008). Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy in Advanced Lymphoma: A Phase II Study. Clinical Lymphoma & Myeloma. 8(4). 241–245. 37 indexed citations

16.

Gebski, Val, Bryan Burmeister, B. Mark Smithers, et al.. (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. The Lancet Oncology. 8(3). 226–234. 912 indexed citations breakdown →

17.

Mangar, Stephen, Kerwyn Foo, A. Norman, et al.. (2006). Evaluating the Effect of Reducing the High-dose Volume on the Toxicity of Radiotherapy in the Treatment of Bladder Cancer. Clinical Oncology. 18(6). 466–473. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact